Table of Contents

I: GENERAL ASPECTS Chapter 1 Principles, Definitions, and Statistics Chapter 2 Nuclear Medicine Chapter 3 Radiation Oncology Chapter 4 Cancer Chemotherapeutic Agents Chapter 5 Supportive Care Chapter 6 Talking with Cancer Patients and Their Families II: SOLID TUMORS Chapter 7 Head and Neck Cancers Chapter 8 Lung Cancer Chapter 9 Gastrointestinal Tract Cancers Chapter 10 Breast Cancer Chapter 11 Gynecologic Cancers Chapter 12 Testicular Cancer Chapter 13 Urinary Tract Cancers Chapter 14 Neurological Tumors Chapter 15 Endocrine Neoplasms Chapter 16 Skin Cancers Chapter 17 Sarcomas Chapter 18 Cancers in Childhood Chapter 19 Miscellaneous Neoplasms Chapter 20 Metastases of Unknown Origin III: HEMATOPOIETIC MALIGNANCIES Chapter 21 Hodgkin and Non-Hodgkin Lymphoma Chapter 22 Plasma Cell Dyscrasias and WaldenstrOm's Macroglobulinemia Chapter 23 Chronic Leukemias Chapter 24 Myeloproliferative Disorders Chapter 25 Acute Leukemia and Myelodysplastic Syndromes IV: COMPLICATIONS Chapter 26 Sexual Function and Pregnancy Chapter 27 Metabolic Complications Chapter 28 Cutaneous Complications Chapter 29 Thoracic Complications Chapter 30 Abdominal Complications Chapter 31 Renal Complications Chapter 32 Neuromuscular Complications Chapter 33 Bone and Joint Complications Chapter 34 Hematologic Complications Chapter 35 Infectious Complications Chapter 36 AIDS-Related Malignancies Chapter 37 Hematopoietic Stem Cell Transplantation Appendix A Glossary of Cytogenetic Nomenclature Appendix B Toxicity of Chemotherapy B1. Major Toxicities and Dose Modifications for Antineoplastic Agents B2. Abridged Common Toxicity Criteria Appendix C Tumor Identifiers C1. Microscopic Clues of Tumor Origin C2. Selected Immunohistochemical Tumor Markers C3. Immunohistochemistry Diagnostic Algorithms C4. Expected Immunophenotypes of Tumors C5. Discriminatory Immunophenotypes for Lymphocytic Neoplasms C6. Classification of Lymphoproliferative Disorders C7. Acute Leukemias: Classification, Cytology, Cytochemistry, and Cytometry> Appendix D Combination Chemotherapy Regimens for Lymphomas D1. Regimens for Hodgkin Lymphoma (HL) D2. Regimens for Non-Hodgkin Lymphoma (NLH) D3. Salvage Regimens for Hodgkin and Non-Hodgkin Lymphoma Index